Saturday, July 11, 2026

Drug profile · INN

bisacodyl

bisacodyl (DULCOLAX) is a unknown. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bisacodyl
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

bisacodyl (DULCOLAX) is a unknown. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN bisacodyl
Brand DULCOLAX
Mechanism Unknown
Route ORAL
Formulation FOR SOLUTION, TABLET, DELAYED RELEASE

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved
TGA approved

Frequently asked questions

What is bisacodyl?

bisacodyl (DULCOLAX) is a unknown. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for bisacodyl?

DULCOLAX is a marketed brand name for bisacodyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bisacodyl?

bisacodyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.